• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

セルロプラスミン遺伝子異常と糖尿病との関連

Research Project

Project/Area Number 09671020
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内分泌・代謝学
Research InstitutionYAMAGATA UNIVERSITY

Principal Investigator

DAIMON Makoto  YAMAGATA UNIVERSITY SCHOOL OF MEDICINE,ASSISTANT PROFESSOR, 医学部, 講師 (20241698)

Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1998: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1997: ¥1,600,000 (Direct Cost: ¥1,600,000)
KeywordsCERULOPLASMIN / DIABETES MELLITUS / セルロプラスミン / 遺伝子
Research Abstract

The Cp gene has been shown as responsible for hereditary ceruloplasmin (Cp) deficiency (HCD), which is an autosomal recessive disease characterized by neurological abnormalities. In many HCD cases, Diabetes mellitus (DM) was the first symptom of the disease, and 10 - 20 years later at age 40 - 60 the neurological abnormalities occurred. The individuals carrying the defective Cp genes in one allele only (heterozygote) have been considered as asymptomatic. But, we made hypothesis that in these individuals the pathogenic changes related to HCD occur slowly, and reach to the levels only to develop DM at late age. To prove this, we have measured serum Cp levels in all DM out-patients in our clinic (about 320 individuals) and affiliated hospitals (about 800 individuals), and found 6 such cases. Genetic analysis of Cp gene revealed that one of them had indeed the gene mutation. Analysis of clinical and laboratorical features of these patients lead us to find that they have brain MRI findings specific to HCD in mild form. These findings together strongly support our hypothesis. Furthermore, we found positive correlation between serum Cp and blood HbA1c levels, indicating that hyperglycemia is a factor for an increase of serum Cp. Serum Cp levels increase with aging, but this increase was attenuated in DM.These findings may contribute to the understanding of the relationship of serum Cp to DM, although further studies such as study using knock out mouse of Cp may be needed to clarify these.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (10 results)

All Other

All Publications (10 results)

  • [Publications] Makoto Daimon, et al.: "NIDDM with a ceruloplasmin gene mutation." Diabetes Care. 20・4. 678-678 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Makoto Daimon, et al.: "Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 Diabetes." Diabetes Care. 21・9. 1525-1528 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Makoto Daimon, et al.: "Hypoceruloplasminemia with hetero-allelic ceruloplasmin gene mutation (Hypo CPGM) : MRI findings of the brain" Neuroradiology. in press.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Makoto Daimon, et al.: "NIDDM with a ceruloplasmin gene mutation." Diabetes Care. 20-4. 678 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Makoto Daimon, et al.: "Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 diabetes" Diabetes Care. 21-9. 1525-1528 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Makoto Daimon, et al.: "Hyprceruloplasminemia with hetero-allelic ceruloplasmin gene mutation(HypoCPGM) : MRI findings of the brain" Neuroradiology. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Makoto Daimon,et al.: "NIDDM with a ceruloplasmin gene mutation" Diabetes Care. 20・4. 678-678 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Makoto Daimon,et al.: "Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 Diabetes" Diabetes Care. 21・9. 1525-1528 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Makoto Daimon,et al: "Hypoceruloplasminemia with hetero-allelic ceruloplasmin gene mutation (Hypo LPGM):MRI findings of the brain" Neuroradiology. (in Press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Makoto Daimon: "NIDDM With a Ceruloplasmin Gene Mufation" Diabetes care. 20・4. 678-678 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi